These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 26970122)

  • 1. The hallmarks of premalignant conditions: a molecular basis for cancer prevention.
    Ryan BM; Faupel-Badger JM
    Semin Oncol; 2016 Feb; 43(1):22-35. PubMed ID: 26970122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precancer Atlas to Drive Precision Prevention Trials.
    Spira A; Yurgelun MB; Alexandrov L; Rao A; Bejar R; Polyak K; Giannakis M; Shilatifard A; Finn OJ; Dhodapkar M; Kay NE; Braggio E; Vilar E; Mazzilli SA; Rebbeck TR; Garber JE; Velculescu VE; Disis ML; Wallace DC; Lippman SM
    Cancer Res; 2017 Apr; 77(7):1510-1541. PubMed ID: 28373404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer prevention as biomodulation: targeting the initiating stimulus and secondary adaptations.
    Furth PA
    Ann N Y Acad Sci; 2012 Oct; 1271(1):1-9. PubMed ID: 23050958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Case for a Pre-Cancer Genome Atlas (PCGA).
    Campbell JD; Mazzilli SA; Reid ME; Dhillon SS; Platero S; Beane J; Spira AE
    Cancer Prev Res (Phila); 2016 Feb; 9(2):119-24. PubMed ID: 26839336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression.
    Denisov EV; Schegoleva AA; Gervas PA; Ponomaryova AA; Tashireva LA; Boyarko VV; Bukreeva EB; Pankova OV; Perelmuter VM
    Lung Cancer; 2019 Sep; 135():21-28. PubMed ID: 31446997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of precancer cell transformation into cancer cells: its relevance to cancer prevention.
    Lupulescu AP
    Cancer Detect Prev; 1996; 20(6):634-7. PubMed ID: 8939350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stomach - Genetic and epigenetic alterations of preneoplastic and neoplastic lesions.
    David S; Meltzer SJ
    Cancer Biomark; 2010; 9(1-6):493-507. PubMed ID: 22112492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precancer in mice: animal models used to understand, prevent, and treat human precancers.
    Cardiff RD; Anver MR; Boivin GP; Bosenberg MW; Maronpot RR; Molinolo AA; Nikitin AY; Rehg JE; Thomas GV; Russell RG; Ward JM
    Toxicol Pathol; 2006; 34(6):699-707. PubMed ID: 17074738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation.
    Singh VN; Gaby SK
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):386S-390S. PubMed ID: 1985417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of genes and molecular pathways involved in the progression of premalignant oral epithelia.
    Banerjee AG; Bhattacharyya I; Vishwanatha JK
    Mol Cancer Ther; 2005 Jun; 4(6):865-75. PubMed ID: 15956244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective induction of apoptosis in mutant p53 premalignant and malignant cancer cells by PRIMA-1 through the c-Jun-NH2-kinase pathway.
    Li Y; Mao Y; Brandt-Rauf PW; Williams AC; Fine RL
    Mol Cancer Ther; 2005 Jun; 4(6):901-9. PubMed ID: 15956247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal metaplasia: a premalignant lesion involved in gastric carcinogenesis.
    Busuttil RA; Boussioutas A
    J Gastroenterol Hepatol; 2009 Feb; 24(2):193-201. PubMed ID: 19215332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precancerous lesions in the kidney.
    Van Poppel H; Nilsson S; Algaba F; Bergerheim U; Dal Cin P; Fleming S; Hellsten S; Kirkali Z; Klotz L; Lindblad P; Ljungberg B; Mulders P; Roskams T; Ross RK; Walker C; Wersäll P
    Scand J Urol Nephrol Suppl; 2000; (205):136-65. PubMed ID: 11144893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microenvironment and pathogenesis of epithelial ovarian cancer.
    Saad AF; Hu W; Sood AK
    Horm Cancer; 2010 Dec; 1(6):277-90. PubMed ID: 21761359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic approaches to accelerate cancer interception.
    Beane J; Campbell JD; Lel J; Vick J; Spira A
    Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.
    Merrick DT; Kittelson J; Winterhalder R; Kotantoulas G; Ingeberg S; Keith RL; Kennedy TC; Miller YE; Franklin WA; Hirsch FR
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2281-8. PubMed ID: 16609045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions.
    Dewanji A; Moolgavkar SH; Luebeck EG
    Math Biosci; 1991 Apr; 104(1):97-109. PubMed ID: 1804458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour biology: senescence in premalignant tumours.
    Collado M; Gil J; Efeyan A; Guerra C; Schuhmacher AJ; Barradas M; Benguría A; Zaballos A; Flores JM; Barbacid M; Beach D; Serrano M
    Nature; 2005 Aug; 436(7051):642. PubMed ID: 16079833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and familial cancer: opportunities for prevention and early detection.
    Li FP
    Cancer Detect Prev; 1986; 9(1-2):41-5. PubMed ID: 3731193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic complexity: a call to action.
    Hait WN; Levine AJ
    Sci Transl Med; 2014 Sep; 6(255):255cm10. PubMed ID: 25253671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.